Other
Number of reportable segments
West Pharmaceutical Services Number of reportable segments remained flat by 0.0% to $2.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.00 to $2.00.
Analysis
StatementIncome Statement
SectionOther
CategoryMarket Position
SignalContext dependent
VolatilityStable
First reportedQ1 2015
Last reportedQ1 2026Apr 23, 2026
How to read this metric
An increase may signal diversification or organizational restructuring, while a decrease often points to simplification or divestiture strategies.
Detailed definition
The total count of distinct business units for which the company reports separate financial results based on internal ma...
Peer comparison
Varies widely by industry; conglomerates typically have more segments than pure-play industrial firms.
Metric ID:
other_number_of_reportable_segmentsHistorical Data
5 periods
| Q1 '22 | Q1 '23 | Q1 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $2.00 | $2.00 | $2.00 | $2.00 | $2.00 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | +0.0% | +0.0% | +0.0% | +0.0% |
Range$2.00 – $2.00
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak4+ quarters growth
Number of reportable segments at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's number of reportable segments?
- West Pharmaceutical Services (WST) reported number of reportable segments of $2.00 in Q1 2026.
- How has West Pharmaceutical Services's number of reportable segments changed year-over-year?
- West Pharmaceutical Services's number of reportable segments decreased by 0.0% year-over-year, from $2.00 to $2.00.
- What does number of reportable segments mean?
- The number of distinct business divisions the company reports on.